Skip to main content
Marcus Goncalves, MD, Endocrinology, New York, NY

MarcusDasilvaGoncalvesMDPhD

Endocrinology New York, NY

Diabetes, Lipid Metabolism

Assistant Professor

Dr. Goncalves is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goncalves' full profile

Already have an account?

  • Office

    222 E 41st Street
    23rd Floor
    New York, NY 10016
    Phone+1 212-481-1350

Summary

  • Dr. Marcus Goncalves is an endocrinologist in New York, NY. He received his medical degree from the University of Pennsylvania and has been in practice 5 years. He specializes in muscle health, diabetes, low testosterone, and lipid metabolism.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2018
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2012

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • American Society of Clinical Investigation 2024

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Suppression of Insulin Feedback Enhances the Efficacy of PI3K Inhibitors  
    Siddhartha Mukherjee, Marcus D Goncalves, Mark A Rubin, Nature
  • Suppression of Insulin Feedback Enhances the Efficacy of PI3K Inhibitors  
    Marcus D Goncalves, Siddhartha Mukherjee, Mark A Rubin, Nature

Lectures

  • Tumor Biology of Breast and Prostate Cancers 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • Fenofibrate Prevents Skeletal Muscle Loss in Mice with Lung Cancer 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018

Press Mentions

  • Earlier Identification of Cachexia in Advanced Cancer Possible
    Earlier Identification of Cachexia in Advanced Cancer PossibleFebruary 18th, 2025
  • Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th
    Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24thJuly 11th, 2024
  • Colon Cancer Risk High with High Fructose Corn Syrup Consumption
    Colon Cancer Risk High with High Fructose Corn Syrup ConsumptionApril 14th, 2019
  • Join now to see all

Grant Support

  • Combination Therapies Targeting Insulin Signaling in Endometrial CancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2028
  • The role of PKM2 in dietary lipid absorption and fructose-induced obesityWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
  • Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell SurvivalNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
  • Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell SurvivalNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
  • The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer CachexiaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2025
  • The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer CachexiaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2025